Sort
64,565 grants matching “drug discovery”
Development of Drugs Acting at Adenosine Receptors
$745,815Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Mid Southern Primary Care Networks Node
$745,791Li-Tzy T Wu · Duke University · UG1 · FY2018 · DA
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine
$745,791Eric J Sorscher · Emory University · R01 · FY2021 · HL
3D-FACS: 3D image-based fluorescence activated cell sorting
$745,729Sung Hwan Cho · Nanocellect Biomedical, Inc. · R44 · FY2019 · DA
JAK1/2 as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target
$745,689David C Fajgenbaum · University Of Pennsylvania · R01 · FY2024 · HL
Protein Tyrosine Dephosphorylation & Signal Transduction
$745,634Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2014 · CA
Peptide Biomarkers for Alzheimer Disease
$745,622Min Shi · University Of Washington · R01 · FY2019 · AG
Accurate accessible cloud software for protein folding for molecular biologists
$745,404Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2016 · GM
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.
$745,398Timothy McKinsey · University Of Colorado Denver · R01 · FY2020 · HL
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.
$745,398Timothy McKinsey · University Of Colorado Denver · R01 · FY2021 · HL
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease
$745,370Li Shen · University Of Pennsylvania · R01 · FY2024 · AG
Synaptic Resilience to Psychosis in Alzheimer Disease
$745,305Robert A Sweet · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · MH
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY
$745,284Colorado State University-Fort Collins · P01 · FY2002 · AI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$745,273Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Modeling hyperactivity in neurological disease using patient-derived pluripotent stem cells
$745,250Fred H Gage · University Of Pennsylvania · U19 · FY2019 · MH
NEUROBIOLOGICAL BASIS OF MAJOR PSYCHIATRIC DISORDERS
$745,233Yale University · P01 · FY2000 · MH
Cell Line Panel Profiling for Discovery of Multiple Myeloma Therapeutics
$745,194Peter Krutzik · Primity, Inc. · R44 · FY2017 · CA
Refinement of lead compounds to modulate water permeability through AQP4
$745,127Marc F Pelletier · Aeromics, Inc · R44 · FY2012 · NS
Pharmacogenomics of Childhood Leukemia ALL
$745,108William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2015 · CA
Detecting pleiotropic effects through integration of omics data
$745,067Andrew Dewan · Yale University · R01 · FY2019 · HL
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$745,015Myron E Essex · Harvard School Of Public Health · R01 · FY2009 · AI
7TMR DRUG DISCOVERY, MICROFLUIDICS &HT FLOW CYTOMETRY
$745,012University Of New Mexico · R24 · FY2003 · EB
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics
$744,984Gabriel Lopez-Berestein · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA
Rapid point-of-care diagnostic reader for Surface enhanced Raman nanotags in a la
$744,932Prasant Potuluri · Centice Corporation · R44 · FY2007 · GM
Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease
$744,923Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AG